research Phytochemical and Therapeutic Evaluation of Curcumin and Piperine in Alopecia
Curcumin and piperine may effectively and safely promote hair regrowth in alopecia.
Search
forResearch
5 / 1000+ results research Microbioreactor design for eukaryotic cell-based biomedical applications
Microbioreactors improve cell-based therapies and personalized medicine but face scalability challenges.
research Synergistic effect of curcumin and Piperine loaded Niosomal nanoparticles on acute pulmonary toxicity induced by Paraquat in mice
Curcumin and piperine together may help protect lungs from paraquat damage.
research A translational approach to improve therapeutics in atopic dermatitis and beyond
New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.
research Wnt is back in drugmakers' sights, but is it druggable?
Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.
Community Join
5 / 233 resultscommunity Stemson Therapeutics and hair cloning pipeline
The conversation discusses the progress and potential of hair cloning by Stemson Therapeutics, questioning if it will be realized in the next 5-10 years or if it's just false hope. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.
community Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
ET-02, a new hair loss treatment, shows promising results with a 6-fold increase in hair count, potentially outperforming minoxidil by activating stem cells in hair follicles. Further trials are ongoing to confirm its efficacy and safety, with potential market release in the future.
community Phase II for Technoderma Therepeutic's TDM-105795 set to begin in April tentatively
Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.
community Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments
AMP-303, a new injectable treatment for androgenetic alopecia, showed promising results in increasing hair count and density with minimal side effects. The treatment demonstrated significant hair regrowth and durability, offering new hope for those with hair loss.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
Clinics
6 / 10 results- 41
Hair Loss TreatmentsTherapeutic AestheticsHamilton, ON · CA - 15Hair Loss TreatmentsTherapeutic Hair Salon & Scalp ClinicMemphis, TN · US
- 26SMPTherapeutic Tattoo - Estudio de tatuaje y micropigmentaciónGijón, Asturias · ES
- 3TrichologyVerbena Therapeutic Cosmetology CenterKursk · RU
- 16
TrichologyMiderm Clinic therapeutic cosmetologyMoscow · RU - 15Hair Loss TreatmentsTrichology Center for Therapeutic Medical CenterNovosibirsk · RU
Experts
1 / 1 resultsLearn
— no results